Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kleanthis G. Xanthopoulos currently holds 23,596 shares of ANADYS PHARMACEUTICALS INC (ANDS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kleanthis G. Xanthopoulos has been a net seller of ANDS stock. They have purchased $35.0K and sold $9.3M worth of shares.
Kleanthis G. Xanthopoulos's most recent insider trade was on Jun 10, 2021, when they sold 15,000 shares at $0.00 per share.
Kleanthis G. Xanthopoulos serves as Executive at ANADYS PHARMACEUTICALS INC (ANDS). They have executed 157 insider transactions totaling $9.4M over their tenure at the company.
Kleanthis G. Xanthopoulos holds the position of Executive at ANADYS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Kleanthis G. Xanthopoulos has shown a selling trading pattern, with $35.0K in total purchases and $9.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kleanthis G. Xanthopoulos was on Mar 5, 2015, when they sold $1.3M worth of RGLS shares. This transaction involved 65,614 shares at $20.06 per share.
Kleanthis G. Xanthopoulos currently owns 23,596 shares of ANADYS PHARMACEUTICALS INC (ANDS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kleanthis G. Xanthopoulos's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kleanthis G. Xanthopoulos has 157 Form 4 filings on record as an insider at ANADYS PHARMACEUTICALS INC.
Set alerts for Kleanthis G. Xanthopoulos and 40,000+ other insiders.